Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease

The use of biological drugs has improved outcomes in pediatric inflammatory bowel disease (IBD). Prediction of the response to biological drugs would be extremely useful in IBD, and even more so in children, who are still growing physically and psychologically. Specific clinical, biochemical, and ge...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sara Salvador-Martín, Alejandra Melgarejo-Ortuño, Luis A. López-Fernández
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
Accès en ligne:https://doaj.org/article/b275a7c3d7d14dff9e7bd172375fb3fe
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!